Ant Group Achieves 2022 Carbon Neutrality Across Its Operations for the Second Consecutive Year
According to figures certified by the China Environmental United Certification Center (“CEC”), Ant Group has once again achieved operational carbon neutrality (Scope 1 & 2) for the second consecutive year, following the company’s initial achievement in 2021. This marks another concrete step for Ant Group towards fulfilling its pledge made in March 2021 to achieve net zero carbon emissions across Scope 1, 2 & 3 by 2030.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230420006073/en/
Through a combination of reduction, substitution and offset measures, Ant Group achieved carbon neutrality in Scope 1 & 2 in 2022. (Graphic: Business Wire)
The Greenhouse Gas Protocol (“Protocol”) classifies a company's Greenhouse Gas Emissions (“GHG”) into Scope 1, 2 and 3. Based on the Protocol, Ant Group, in its Carbon Neutrality Road Map, released in April 2021 , defined its GHG emissions scopes as follows:
- Scope 1: direct & fugitive emissions from the combustion of fossil fuel by the company’s owned or controlled sources.
- Scope 2: indirect emissions from the consumption of purchased energy, such as heating or cooling networks.
- Scope 3: indirect emissions which occur in the company's value chain, such as emissions from the use of leased data centers, employees’ business travel and their daily commute.
According to CEC certified figures, in 2022, after reductions and substitutions, Ant Group's greenhouse gas (GHG) emissions for Scope 1 & 2 totaled 21,087.93 tonnes of CO2e, which were fully offset by the company’s purchase of carbon credits from a Verified Carbon Standard (VCS) Project, namely the CECIC Gansu Yumen Changma No.3 Wind Farm Project (VCS Project No.728).
CEC certified figures indicate that Ant Group reduced a total of 68,665.35 tonnes of CO2e across Scope 1, 2 & 3 in 2022, up 81% from 37,909.87 tonnes in 2021. This is equivalent to taking more than 28,000 cars off the road each year, assuming each car is driven 12,000 kilometers per year at 0.203 kilogram of CO2e per kilometer. The CEC was an official service provider to the 2022 Winter Olympics, helping the Olympic Committee measure the effectiveness of its carbon reduction efforts.
This reduction was mainly due to the implementation of green computing technologies. These technologies reduced about 62,000 tonnes of CO2e, which accounted for more than 99% of all carbon emissions reduced in Scope 3 during 2022. This was a 110% improvement over the 30,000 tonnes of CO2e that green computing technologies reduced in 2021.
“At Ant Group, we believe a company’s commercial value creation should go hand in hand with social value creation,“ said Yijie Peng, Chief Sustainability Officer of Ant Group. “Technological innovations has always been an important pathway for us to achieve this goal. We are committed to reaching net zero carbon emissions by 2030 and will continue to explore innovative ways to help reduce our carbon footprint and that of the industry.”
Ant Group has been developing and adopting green computing technologies since 2019. These technologies include Green AI, a series of technologies such as elastic management, GPU memory pooling and virtualization, which make large-scale model training more efficient.
For example, ATorch, Ant Group's PyTorch extension library, can double the utilization rate of AI computing power in large GPU cluster configurations compared to Megatron-DeepSpeed, an opensource deep learning optimization software suite. The use of ATorch has led to energy efficiency gains and carbon emission reductions for AI model training operations, which the company uses to iterate its AI-based products and services for better customer experience.
Ant Group also uses other green computing technologies, such as online-offline hybrid deployment, cloud-native time-shared scheduling, AI-based auto scaling, and OceanBase enterprise-level distributed relational database to help improve energy efficiency of data centers.
In 2022, Ant Group joined the Low Carbon Patent Pledge and granted free patent access to its green computing technologies.
The CEC’s carbon neutrality certificate for Ant Group for the year 2022 is publicly available on the Information Platform for Carbon Neutrality, which is affiliated with the Environmental Development Center of China’s Ministry of Ecology and Environment.
About Ant Group
Ant Group aims to create the infrastructure and platform to support the digital transformation of the service industry. It strives to enable all consumers and small and micro businesses to have equal access to financial and other services that are inclusive, green and sustainable.
For more information, please visit our website at www.antgroup.com or follow us on Twitter @AntGroup.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230420006073/en/
Contact information
Media Enquiries
Zhumei WANG
zhumei.wzm@antgroup.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67 th American Society of Hematology (ASH) Annual Meeting6.12.2025 16:30:00 EET | Press release
Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which Ono obtained exclusive global rights for the development and commercialization of sapablursen. “In the treatment of PV, phlebotomy and cytoreductive therapy are performed as treatments for preventing thrombosis. Phlebotomy is the most common treatment for PV, in which blood
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 16:30:00 EET | Press release
Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition. These findings further reinforce rusfertide’s efficacy and safety and demonstrate durability of response, with 61.9% of patients continuously treated with rusfertide maintaining absence of phlebotomy eligibility from baseline to Week 52. “The 52-week data demonstrated the sustained efficacy of rusfertide, reducing the need for patients to receive phlebotomy while maintaining hematocrit control,” said Dr. Andrew T. Kuykendall, M.D., VERIFY Lead Investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center. “The 32-week VERIFY primary results were already promising, and this deeper understanding of the durability of r
Vertex Presents New Data on CASGEVY ® , Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 14:01:00 EET | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and TDT ages 12 years and older, will be presented at the American Society of Hematology (ASH) Annual Meeting. CASGEVY is currently approved for eligible people ages 12 years and older with SCD or TDT in the United States, Great Britain, the European Union, the Kingdom of Saudi Arabia, the Kingdom of Bahrain, Kuwait, Qatar, Canada, Switzerland and the United Arab Emirates. “These results — the first clinical data ever presented on any genetic therapy for children ages 5-11 years with SCD — again demonstrate the tr
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 13:31:00 EET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 01:49:00 EET | Press release
Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive Officer, Lattice Semiconductor. The annual GSA Awards celebrate the accomplishments of the semiconductor indu
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
